Why Adverse Outcome Pathways Need to be FAIR

Clemens Wittwehr,Laure-Alix Clerbaux,Stephen Edwards, Michelle Angrish,Holly Mortensen,Annamaria Carusi,Maciej Gromelski, Eftychia Lekka, Vassilis Virvilis,Marvin Martens, Luiz Olavo Bonino da Silva Santos,Penny Nymark

ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION(2024)

引用 0|浏览32
暂无评分
摘要
Adverse outcome pathways (AOPs) provide evidence for demonstrating and assessing causality between measurable toxicological mechanisms and human or environmental adverse effects. AOPs have gained increasing attention over the past decade and are believed to provide the necessary steppingstone for more effective risk assessment of chemicals and materials and moving beyond the need for animal testing. However, as with all types of data and knowledge today, AOPs need to be reusable by machines, i.e., machine-actionable, in order to reach their full impact potential. Machine-actionability is supported by the FAIR principles, which guide findability, accessibility, interoperability, and reusability of data and knowledge. Here, we describe why AOPs need to be FAIR and touch on aspects such as the improved visibility and the increased trust that FAIRification of AOPs provides.
更多
查看译文
关键词
adverse outcome pathways
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要